“Our findings show we can potentially achieve tumor control and provide patients with more successful cancer treatments,” said author Antonio Jimeno, director of the Head and Neck Cancer Program at the University of Colorado School of Medicine and co-leader of Development Therapeutics Program at the University of Colorado Cancer Center.